Cargando…
STIMULATE-ICP: A pragmatic, multi-centre, cluster randomised trial of an integrated care pathway with a nested, Phase III, open label, adaptive platform randomised drug trial in individuals with Long COVID: A structured protocol
INTRODUCTION: Long COVID (LC), the persistent symptoms ≥12 weeks following acute COVID-19, presents major threats to individual and public health across countries, affecting over 1.5 million people in the UK alone. Evidence-based interventions are urgently required and an integrated care pathway app...
Autores principales: | Forshaw, Denise, Wall, Emma C., Prescott, Gordon, Dehbi, Hakim-Moulay, Green, Angela, Attree, Emily, Hismeh, Lyth, Strain, William D., Crooks, Michael G., Watkins, Caroline, Robson, Chris, Banerjee, Rajarshi, Lorgelly, Paula, Heightman, Melissa, Banerjee, Amitava |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931100/ https://www.ncbi.nlm.nih.gov/pubmed/36791116 http://dx.doi.org/10.1371/journal.pone.0272472 |
Ejemplares similares
-
STIMULATE-ICP-Delphi (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways Delphi): Study protocol
por: van der Feltz-Cornelis, Christina M., et al.
Publicado: (2022) -
Sample size calculation in randomised phase II selection trials using a margin of practical equivalence
por: Dehbi, Hakim-Moulay, et al.
Publicado: (2020) -
Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study
por: Dennis, Andrea, et al.
Publicado: (2021) -
Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards
por: Dehbi, Hakim-Moulay, et al.
Publicado: (2017) -
Multi-organ impairment and long COVID: a 1-year prospective, longitudinal cohort study
por: Dennis, Andrea, et al.
Publicado: (2023)